Continuous positive airway pressure (CPAP) is an effective treatment for obstructive sleep apnea hypopnea syndrome (OSAHS), but previous studies assessing the effect of CPAP on leptin in patients with OSAHS yielded conflicting results. In this study, we conducted a meta-analysis to determine whether CPAP therapy could reduce serum leptin levels.
Data Sources
Databases of PubMed, Elsevier, and SCI were thoroughly searched by 2 independent reviewers.
Methods
RevMan (version 5.2) was used for data synthesis. Weighted mean difference (WMD) before and after CPAP therapy was calculated to estimate the effects of CPAP therapy.
Results
A total of 11 studies involving 413 participants were included. Meta-analysis showed that the total WMD for leptin levels was 1.44 units (95% confidence interval: 1.11-1.77, P < .01) before and after CPAP therapy. Subgroup analysis exhibited that leptin was decreased within 3 days after the therapy, and it was further reduced within 1 to 3 months and beyond.
Conclusions
The results of our meta-analysis showed that CPAP could significantly reduce leptin levels in OSAHS patients without concomitant weight loss.
XiaoYChenXShiH. Evaluation of airway obstruction at soft palate level in male patients with obstructive sleep apnea/hypopnea syndrome: dynamic 3-dimensional CT imaging of upper airway. J Huazhong Univ Sci Technolog Med Sci. 2011;31:413-418.
3.
PeppardPEYoungTBarnetJH. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006-1014.
4.
MarikPE. Leptin, obesity, and obstructive sleep apnea. Chest. 2000;118:569-571.
5.
FriedmanJMHalaasJL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770.
6.
FruhbeckGJebbSAPrenticeAM. Leptin: physiology and pathophysiology. Clin Physiol. 1998;18:399-419.
7.
SandersMH. Article reviewed: serum leptin and vascular risk factors in obstructive sleep apnea. Sleep Med. 2001;2:161-163.
8.
YeeBJCheungJPhippsP. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration. 2006;73:209-212.
9.
HarschIAKonturekPCKoebnickC. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003;22:251-257.
10.
DrummondMWinckJCGuimaraesJT. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med. 2008;8:21.
11.
ManzellaDParilloMRazzinoT. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord. 2002;26:370-375.
12.
HarschIASchahinSPBrucknerK. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004;71:252-259.
13.
Aizawa-AbeMOgawaYMasuzakiH. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000;105:1243-1252.
14.
KonstantinidesSSchaferKKoschnickS. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001;108:1533-1540.
15.
CuhadarogluCUtkusavasAOzturkL. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009;187:75-81.
16.
KiefferTJHellerRSHabenerJF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun. 1996;224:522-527.
17.
PiattiPDi MarioCMontiLD. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation. 2003;108:2074-2081.
18.
YatagaiTNagasakaSTaniguchiA. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism. 2003;52:1274-1278.
19.
HarschIASchahinSPRadespiel-TrogerM. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169:156-162.
20.
MalhotraAAyasNTEpsteinLJ. The art and science of continuous positive airway pressure therapy in obstructive sleep apnea. Curr Opin Pulm Med. 2000;6:490-495.
21.
WestSDKohlerMNicollDJ. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med. 2009;10:1056-1058.
22.
TsaraVKaimakamisESerasliE. Health related quality of life in Greek patients with sleep apnea-hypopnea syndrome treated with continuous positive airway pressure. Sleep Med. 2009;10:217-225.
23.
D’AmbrosioCBowmanTMohseninVQuality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure—a prospective study. Chest. 1999;115:123-129.
GarciaJMSharafkhanehHHirshkowitzM. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011;12:80.
26.
MacreaMMMartinTJZagreanL. Infertility and obstructive sleep apnea: the effect of continuous positive airway pressure therapy on serum prolactin levels. Sleep Breath. 2010;14:253-257.
27.
BarceloABarbeFLlompartE. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med. 2005;171:183-187.
28.
HuangRHuangXZWangHG. [Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;26:168-171.
29.
SannerBMKollhosserPBuechnerN. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J. 2004;23:601-604.
30.
ChinKNakamuraTTakahashiK. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med. 2003;114:370-376.
31.
ChinKShimizuKNakamuraT. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100:706-712.
32.
MantelNHaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-478.
33.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med200221:1539-1558.
34.
HigginsJPThompsonSGDeeksJJ. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
35.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
36.
EggerMDavey SmithGSchneiderM. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
37.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
38.
DuvalSTweedieR. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463.
39.
HoyosCMKillickRYeeBJ. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. 2012;67:1081-1089.
40.
Sanchez-de-la-TorreMMedianoOBarceloA. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath. 2012;16:649-656.
41.
TasaliEChapototFLeproultR. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96:365-374.
42.
YamamotoYFujiuchiSHiramatsuM. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration. 2008;76:377-385.
43.
HarschIAKoebnickCWallaschofskiH. Resistin levels in patients with obstructive sleep apnoea syndrome—the link to subclinical inflammation?Med Sci Monit. 2004;10:CR510-%15.
44.
KumorMBielickiPPrzybylowskiT. [Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)]. Pneumonol Alergol Pol. 2011;79:173-183.
45.
RubinsztajnRKumorMByskiniewiczK. [The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol. 2006;74:63-67.
46.
PetrisorBAKeatingJSchemitschE. Grading the evidence: levels of evidence and grades of recommendation. Injury. 2006;37:321-327.
47.
VgontzasANTanTLBixlerEO. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154:1705-1711.
48.
RichmanRMElliottLMBurnsCM. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994;18:173-177.
49.
MoraesWPoyaresDZalcmanI. Association between body mass index and sleep duration assessed by objective methods in a representative sample of the adult population. Sleep Med. 2013;14:312-318.
MaffeiMHalaasJRavussinE. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155-1161.
52.
Van CauterESpiegelKTasaliE. Metabolic consequences of sleep and sleep loss. Sleep Med. 2008;9(suppl 1):S23-S28.
SnitkerSPratleyRENicolsonM. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res. 1997;5:338-340.
55.
SaladinRDe VosPGuerre-MilloM. Transient increase in obese gene expression after food intake or insulin administration. Nature. 1995;377:527-529.
56.
ManyariDEWangZCohenJ. Assessment of the human splanchnic venous volume-pressure relation using radionuclide plethysmography: effect of nitroglycerin. Circulation. 1993;87:1142-1151.
57.
EslerMVazMCollierG. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet. 1998;351:879.
58.
KapsimalisFVarouchakisGManousakiA. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung. 2008;186:209-217.
59.
FriedmanMSamuelsonCGHamiltonC. Effect of continuous positive airway pressure on C-reactive protein levels in sleep apnea: a meta-analysis. Otolaryngol Head Neck Surg. 2012;147:4234-4233.
60.
GuoYPanLRenD. Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2013;17:495-503.
